Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Remove filter for
Type: Recall
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 121 - 135 of 180 items.
Privigen: Series of adverse reactions
RecallHealth product recall | 2022-12-01
Teva-Atenolol; Product label image incorrect
RecallHealth product recall | 2022-11-21
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Menopur: Potential for a future out of specification result during shelf life
RecallHealth product recall | 2022-09-28
Lumi Lash: Unlicensed product with ingredient on prescription drug list.
RecallHealth product recall | 2022-09-26
Esomeprazole, Candesartan and Pravastatin Tablets: OOS result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
Venlafaxine: OOS result for Spheroids Dissolution Rate Profile (DRP)
RecallHealth product recall | 2022-09-21
Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
Menopur: Out of specification (Assay)
RecallHealth product recall | 2022-08-31
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Jamp-Vitamin D: Out of Specification
RecallHealth product recall | 2022-08-22
Taro-Zoledronic Acid: The affected lots may contain particulate matter
RecallHealth product recall | 2022-08-10
JAMP-ATORVASTATIN: The affected lot may contain latex.
RecallHealth product recall | 2022-08-08